Roche to Acquire PathAI for $750M in AI Diagnostics Push
Roche agrees to acquire digital pathology company PathAI for $750M upfront, plus up to $300M in milestone payments, expa…
8 articles about 'AI diagnostics'
Roche agrees to acquire digital pathology company PathAI for $750M upfront, plus up to $300M in milestone payments, expa…
Swiss pharma giant Roche agrees to buy digital pathology startup PathAI for $750M upfront, with up to $300M in milestone…
Beijing Academy of Artificial Intelligence unveils an AI-powered diagnostic agent for cardiac MRI analysis, dramatically…
Major South Korean hospitals deploy AI-powered diagnostic tools that detect early-stage cancers with over 95% accuracy, …
OpenAI's o1 reasoning model correctly diagnosed 67% of emergency room patients, significantly outperforming triage docto…
Japanese researchers advocate expanding AI adoption in medical labs and diagnostics to reduce errors and free staff from…
AI models now outscore physicians on diagnostic tests, but the real story is more nuanced than the headlines suggest.
A Harvard-led study finds large language models, particularly GPT-4, delivered more accurate diagnoses than emergency ro…